1. Department of Rheumatology, Ome Municipal General Hospital, Tokyo, Japan;
2. Department of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan;
3. Division of Epidemiology and Pharmacoepidemiology, Department of Rheumatology, School of Medicine, Tokyo Women’s Medical University, Tokyo, Japan;
4. Division of Hematology and Rheumatology, Teikyo University Chiba Medical Center, Chiba, Japan;
5. Department of Environmental and Preventive Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Ishikawa, Japan;
6. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan;
7. Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
8. Department of Nephrology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan;
9. Department of Rheumatology, Niigata Rheumatic Center, Niigata, Japan;
10. Department of Rheumatology, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan;
11. Department of Nephrology and Rheumatology, First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan;
12. Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan;
13. Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan;
14. Department of General Medicine, Tokyo Kita Medical Center, Tokyo, Japan;
15. Department of Health Informatics, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan;
16. Department of Nephrology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan;
17. Department of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan